Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium

NCT03097003 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT03097003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03097003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
April 6, 2017
Completion date
December 20, 2018
Enrollment
124 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis